Cite
Immunohistochemical study of pElk-1 expression in human breast cancer: association with breast cancer biologic profile and clinicopathologic features.
MLA
Laliotis, Aggelos, et al. “Immunohistochemical Study of PElk-1 Expression in Human Breast Cancer: Association with Breast Cancer Biologic Profile and Clinicopathologic Features.” Breast (Edinburgh, Scotland), vol. 22, no. 1, Feb. 2013, pp. 89–95. EBSCOhost, https://doi.org/10.1016/j.breast.2012.09.013.
APA
Laliotis, A., Vrekoussis, T., Kafousi, M., Sanidas, E., Askoxilakis, J., Melissas, J., Mavroudis, D., Castanas, E., & Stathopoulos, E. N. (2013). Immunohistochemical study of pElk-1 expression in human breast cancer: association with breast cancer biologic profile and clinicopathologic features. Breast (Edinburgh, Scotland), 22(1), 89–95. https://doi.org/10.1016/j.breast.2012.09.013
Chicago
Laliotis, Aggelos, Thomas Vrekoussis, Maria Kafousi, Elias Sanidas, John Askoxilakis, John Melissas, Dimitrios Mavroudis, Elias Castanas, and Efstathios N Stathopoulos. 2013. “Immunohistochemical Study of PElk-1 Expression in Human Breast Cancer: Association with Breast Cancer Biologic Profile and Clinicopathologic Features.” Breast (Edinburgh, Scotland) 22 (1): 89–95. doi:10.1016/j.breast.2012.09.013.